FOLFOX-Bevacizumab Regimen

Preferred Label : FOLFOX-Bevacizumab Regimen;

NCIt synonyms : FOLFOX Plus Bevacizumab; FOLFOX/Avastin Regimen; FOLFOX-Avastin Regimen; Folinic Acid/Fluorouracil/Oxaliplatin/Bevacizumab Regimen; FOLFOX/Bevacizumab Regimen; FOLFOX Plus Avastin; Leucovorin/Fluorouracil/Oxaliplatin/Bevacizumab; Folfox Bevacizumab Regimen; Folfox Bevacizumab;

NCIt definition : A chemoimmunotherapy regimen consisting of leucovorin, fluorouracil and oxaliplatin (FOLFOX), plus bevacizumab that is used for the treatment of colon cancer.;

NCI Metathesaurus CUI : CL523559;

Details

Origin ID

C136248;

UMLS CUI

C4526521;

Est indiqué pour
- Rectal Carcinoma [NCIt concept]
- cancer of rectum [MeSH concept]
Semantic type(s)
- Therapeutic or Preventive Procedure [UMLS semantic type]
chemotherapy_regimen_has_component
- Bevacizumab [NCIt concept]
- Fluorouracil [NCIt concept]
- Leucovorin Calcium [NCIt concept]
- Oxaliplatin [NCIt concept]
concept_is_in_subset
- Multi-agent Therapeutic Regimens [NCIt concept]
- Pharmacotherapy Regimens [NCIt concept]
regimen_has_accepted_use_for_disease
- Colorectal Carcinoma [NCIt concept]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients